Paul Rothman B.'s most recent trade in Merck & Co Inc was a trade of 2,863 Phantom Stock done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Company | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2025 | 2,863 | 31,990 | - | - | Phantom Stock | |
| Labcorp | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Labcorp | Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 1,674 (0%) | 0% | - | Common Stock | |
| Labcorp | Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Labcorp | Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 717 | 944 | - | - | Restricted Stock Unit | |
| Labcorp | Paul B. Rothman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 717 | 717 (0%) | 0% | - | Common Stock | |
| Merck & Company | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,752 | 28,233 | - | - | Phantom Stock | |
| Labcorp | Paul Rothman B. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,661 | - | - | Restricted Stock Unit | |
| Labcorp | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 642 | 642 | - | - | Restricted Stock Unit | |
| Merck & Company | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,980 | 25,797 | - | - | Phantom Stock | |
| Merck & Company | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 2,363 | 23,152 | - | - | Phantom Stock | |
| Merck & Company | Paul B. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 2,635 | 19,522 | - | - | Phantom Stock |